Submission date
12/09/2003
Registration date
12/09/2003
Last edited
07/04/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Surgery
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results not expected as study has stopped
Raw data not expected as study has stopped
Study stopped

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Mr Christopher Watson

ORCID ID

Contact details

Honorary Consultant Surgeon
University Department of Surgery
Box 202
Addenbrooke's Hospital
Cambridge
CB2 2QQ
United Kingdom
+44 (0)1223 336980
cjew2@cam.ac.uk

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N0544103857

Study information

Scientific title

Acronym

Study hypothesis

N-Acetylcysteine in liver transplantation

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Not Specified

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet.

Condition

Surgery: Liver transplant

Intervention

Patients undergoing liver transplantation will be randomly allocated to the N-Acetylcysteine group or a control group (no treatment).
Treatment will commence during the liver transplant and continue for 5 days post-operatively. Blood tests and liver biopsies will be taken during the study for analysis.

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Not Specified

Drug/device/biological/vaccine name(s)

N-Acetylcysteine

Primary outcome measure

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall study start date

06/09/2001

Overall study end date

01/09/2007

Reason abandoned (if study stopped)

Lack of staff/facilities/resources

Eligibility

Participant inclusion criteria

Added May 2008:
Adult patients (≥18years) undergoing liver transplant

Participant type(s)

Patient

Age group

Adult

Lower age limit

18 Years

Sex

Not Specified

Target number of participants

Added May 2008:
170 patients would give 90% power but trial stopped.

Participant exclusion criteria

Added May 2008:
Allergy to n-acetyl cysteine

Recruitment start date

06/09/2001

Recruitment end date

01/09/2007

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

Honorary Consultant Surgeon
Cambridge
CB2 2QQ
United Kingdom

Sponsor information

Organisation

Department of Health (UK)

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.doh.gov.uk

Funders

Funder type

Government

Funder name

Cambridge Consortium - Addenbrooke's (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?

Additional files

Editorial Notes